Vistagen Therapeutics (VTGN) Q2 2025 Earnings

Jun 17Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.46
-0.4
-0.35

Details

Expected EPS
-0.496667
Actual EPS
-0.43
Surprise EPS
0.07
Surprise Percent
+13.42%

Description

⁨Vistagen Therapeutics⁩ (⁦VTGN⁩) has reported earnings of ⁦-0.43⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts